ABSTRACT
The postoperative course was characterized by a slight improvement of the preoperative symptoms. He underwent chemotherapy and radiotherapy. A 6 month-postoperative MRI documented tumoral re-growth, for which a reoperation was proposed. However, the patient refused. In the next four months, he experienced a progressive sensory deterioration, until a state of coma and subsequent death.
█ INTRODUCTION
T he embryonal tumors other than medulloblastoma represent a heterogeneous group of malignancies characterized by poorly differentiated neuroepithelial cells and generally aggressive behavior, localized in the supratentorial compartment. They have been historically indicated as supratentorial primitive neuroectodermal tumor (sPNET) (6) . These tumors occur prevalently in children, representing about 2.8% of all primary brain tumors of childhood and adolescence. They represent an extremely rare occurrence in elderly patients aged 60 years or older, raising many issues on the diagnostic pitfalls and management strategy (1, 3, 4, 5, 7, 10, 12, 13, 15) .
We report the case of a 62-year-old man affected by a temporo-insular embryonal tumor with a review of the most relevant literature, addressing the specific issue of differential diagnosis and the expected results in the elderly population.
Supratentorial embryonal tumors are very rare malignant tumors of neuroectodermal origin, characterized by an aggressive clinical behavior. They occur prevalently in children. They have been sporadically described in adults and represent an even rarer occurrence in elderly patients, raising many issues on the diagnostic pitfalls and their appropriate management. We present an unusual case of embryonal tumor in a 62-year-old man who presented with speech disorder, and partial deficit of the left 3 rd and 5 th cranial nerves secondary to a left temporo-insular embryonal tumor: the clinico-radiological features, histopathological insights, therapeutic options and results are discussed along with a review of the most relevant literature, addressing the specific issue of differential diagnosis and the expected results in the elderly population. Recent studies have shown that adult sPNET cases present some significant differences: high incidence of TP53 mutations, no amplification of the c-myc/N-myc genes, and presence of IDH1 mutations (2).
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The incidence of cases reported in the adult population is extremely low, accounting for less than 0.5%; they occur prevalently in the third decade of life, resembling the presence of two peaks in the age profile for sPNET onset: childhood and middle age (5, 15) . During the last decade, the interest on adult patients affected by sPNET has increased progressively due 
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to the better identification of these tumors (5, 15) . According to the literature review, there are only 20 cases of patients aged 60 years or older reported so far, who deserve a particular discussion (Table I) .
Patients ranged in age from 60 to 88 years (mean 68.6 years) with a male predominance (ratio 2.5:1). In these cases, most of the lesions were located in the temporal and parietal lobes, compared with a prevalent localization in the frontal lobe in adult patients (15) ; one patient had a corpus callosum seeding, whereas bilateral ventricles lesions were observed in another one. None of them had a pineal localization, as reported in the general adult series (15) .
The most common presenting symptoms were focal neurological deficits and intracranial hypertension-related symptoms; seizures, frequently occurring in children, were not reported.
On neuroradiological examination, sPNETs appeared as large masses, rarely associated with necrosis cysts, calcification and hemorrhage (11) . They displayed heterogeneous signal intensity, with the solid portion of the tumor typically showing hypointensity on T1-weighted images and hyperintensity on T2-weighted images; intense homogenous enhancement was often described on contrasted T1-weighted sequences. Peritumoral edema was also depicted (5, 11) . On the basis of these findings, the rarity of this tumor in the elderly may raise some difficulties in the differential diagnosis. sPNET in adults usually looks like a high-grade astrocytoma or anaplastic oligodendroglioma on computed tomography and MRI; however tumor cyst, calcification and lobulating contour with good demarcation may be more frequently observed in sPNET than in high-grade gliomas. It may appear more similar to a meningioma as in our case. This hypothesis is sustained by epidemiological data (meningiomas are common intracranial neoplasms with a maximum incidence between the fifth and sixth decade), presence of degenerative necrotic -cyst/pseudocyst, perilesional edema (depicted in 60% of meningiomas) and intense and homogeneous contrast enhancement with a "dural tail" sign associated (5, 8, 14) .
The initial staging should include spinal MRI and cerebrospinal fluid (CSF) cytology, in order to plan cranio-spinal radiotherapy or intrathecal chemotherapy, as generally applied in children. Indeed, CSF spreading is one of the few prognostic factors correlated with outcome in adult sPNET (15) .
Age was the other factor associated with worse survival. According to Zheng et al.(15) , the 1 year survival rate is better for patients aged <60 years (83.3% versus 40%), although not statistically significant.
Generally speaking, sPNET in adults are rarer and usually have a worse prognosis compared to their infratentorial counterpart (medulloblastomas), as well as compared with sPNET in the pediatric population. More than 2/3 of the entire series of elderly patients died after a mean follow-up of 10.9 months (range 2-62 months) (5, 13, 15) . Due to the small number of cases analysed, we are not able to draw conclusions, especially with regard to those patients who had a better clinical follow-up; however, data emerging from the literature depicted age at onset, surgical resection, extent of resection and radiotherapy as good prognostic factors (15). Zheng et al. observed that radiotherapy and both chemotherapy and Not specified radiotherapy were marginally significant for better survival, whereas chemotherapy alone did not improve survival at all (15) . However, due to a relative radioresistance of these tumors compared to medulloblastoma, the addition of multiregimen chemotherapy is considered of therapeutic value.
█ CONCLUSION
There is a general agreement to consider complete removal of the tumor when feasible; followed by adjuvant radiotherapy and chemotherapy, even in elderly patients should the general conditions allow the entire treatment.
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